This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biocon Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Thangarasu Ponnusamy: Innovator in Pharmaceutical Chemistry
Introduction
Thangarasu Ponnusamy is a notable inventor based in Coimbatore, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has led to advancements in medication formulations that can improve patient outcomes.
Latest Patents
Thangarasu holds a patent for a groundbreaking invention titled "Crystalline linagliptin intermediate and process for preparation of linagliptin." This patent presents novel crystalline forms B1 and B2 of the linagliptin intermediate, along with methods for their production. The structural formula V is central to this innovation, showcasing his expertise in creating effective pharmaceutical intermediates.
Career Highlights
Thangarasu Ponnusamy is currently employed at Biocon Limited, a leading biopharmaceutical company. His role involves extensive research and development, focusing on innovative solutions in drug formulation. His contributions have been instrumental in enhancing the company's portfolio of pharmaceutical products.
Collaborations
Thangarasu has collaborated with esteemed colleagues, including Venkata Raghavendracharyulu Palle and Shanmughasamy Rajmahendra. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thangarasu Ponnusamy's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent on crystalline linagliptin intermediates highlights his commitment to advancing drug development. Through his career at Biocon Limited and collaborations with fellow researchers, he continues to make a significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
